Literature DB >> 10375096

Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer.

K Heinimann1, R J Scott, J M Buerstedde, W Weber, K Siebold, M Attenhofer, H Müller, Z Dobbie.   

Abstract

BACKGROUND: Hereditary nonpolyposis colorectal cancer (HNPCC) is linked genetically to mutations in DNA mismatch repair (MMR) genes. Because a deficiency in MMR does not predict a specific phenotype, the original selection criteria may be too restrictive in identifying additional families. The current study was performed to determine whether a relaxation of the Amsterdam criteria (AC) could be applied to identify more families associated with DNA MMR.
METHODS: Twenty-eight unrelated Swiss families (15 complying with the AC and 13 fulfilling extended criteria [EC] to include other tumors of the HNPCC spectrum as well) were screened for mutations in the MMR genes hMSH2 and hMLH1, using single-stranded conformation polymorphism and direct DNA sequencing. Microsatellite instability (MSI) was determined in 14 families. A comparison was made between the phenotypic characteristics of the mutation positive and mutation negative families.
RESULTS: Ten AC families (67%) harbored germline mutations in hMLH1 (6 kindreds) or hMSH2 (4 kindreds). In none of the EC kindreds could an unambiguous disease-causing mutation be identified. Seven of eight AC families were found to display MSI whereas all colorectal carcinomas (CRC) in eight EC kindreds were MSI stable. CRC patients from mutation positive families had an earlier age at diagnosis (44 years vs. 49 years) and appeared to have a better survival (11.1 years vs. 7.7 years).
CONCLUSIONS: Extending the AC to include extracolonic tumors of the HNPCC spectrum results in a very low mutation detection rate for hMSH2 and hMLH1. The EC families appear to represent an alternative genetic entity not necessarily related to DNA MMR gene mutations because they do not display MSI.

Entities:  

Mesh:

Year:  1999        PMID: 10375096     DOI: 10.1002/(sici)1097-0142(19990615)85:12<2512::aid-cncr4>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.

Authors:  R J Scott; M McPhillips; C J Meldrum; P E Fitzgerald; K Adams; A D Spigelman; D du Sart; K Tucker; J Kirk
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

2.  Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis?

Authors:  Martin Kruschewski; Aurelia Noske; Jörg Haier; Norbert Runkel; Yanis Anagnostopoulos; Heinz Johannes Buhr
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

3.  Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer.

Authors:  Y Mueller-Koch; H Vogelsang; R Kopp; P Lohse; G Keller; D Aust; M Muders; M Gross; J Daum; U Schiemann; M Grabowski; M Scholz; B Kerker; I Becker; G Henke; E Holinski-Feder
Journal:  Gut       Date:  2005-06-14       Impact factor: 23.059

4.  CLINICAL MANAGEMENT OF FAMILIES WITH HEREDITARY COLORECTAL CANCER SYNDROMES.

Authors:  Monica Dandapani; Elena M Stoffel
Journal:  Semin Colon Rectal Surg       Date:  2011-06-01

5.  Novel hMSH2, hMSH6 and hMLH1 gene mutations and microsatellite instability in sporadic colorectal cancer.

Authors:  P Chaksangchaichot; P Punyarit; S Petmitr
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-11       Impact factor: 4.553

Review 6.  Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.

Authors:  Scott M Weissman; Cecelia Bellcross; Christina Chimera Bittner; Mary E Freivogel; Joy Larsen Haidle; Pardeep Kaurah; Anna Leininger; Selvi Palaniappan; Kelle Steenblock; Thuy M Vu; Molly S Daniels
Journal:  J Genet Couns       Date:  2010-10-08       Impact factor: 2.537

7.  Some aspects of molecular diagnostics in Lynch syndrome.

Authors:  Grzegorz Kurzawski
Journal:  Hered Cancer Clin Pract       Date:  2006-12-15       Impact factor: 2.857

8.  Deletion Mutations in an Australian Series of HNPCC Patients.

Authors:  Mary McPhillips; Cliff J Meldrum; Rhona Creegan; Edward Edkins; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2005-11-15       Impact factor: 2.857

9.  Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients.

Authors:  Jin C Kim; Seon A Roh; Kum H Koo; In H Ka; Hee C Kim; Chang S Yu; Kang H Lee; Jung S Kim; Han I Lee; Walter F Bodmer
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

10.  Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.

Authors:  Dandan Li; Fulan Hu; Fan Wang; Binbin Cui; Xinshu Dong; Wencui Zhang; Chunqing Lin; Xia Li; Da Wang; Yashuang Zhao
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.